$CLFD
Clearfield, Inc.

2020 Q4 Form 10-Q Financial Statement

#000117184321000707 Filed on February 03, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4
Revenue $27.09M $19.38M
YoY Change 39.81% -3.54%
Cost Of Revenue $15.72M $11.65M
YoY Change 34.96% -4.05%
Gross Profit $11.37M $7.728M
YoY Change 47.12% -2.76%
Gross Profit Margin 41.96% 39.88%
Selling, General & Admin $7.656M $7.327M
YoY Change 4.5% 8.13%
% of Gross Profit 67.34% 94.81%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $568.0K $607.0K
YoY Change -6.42% 14.65%
% of Gross Profit 5.0% 7.85%
Operating Expenses $7.656M $7.327M
YoY Change 4.5% 8.13%
Operating Profit $3.713M $400.9K
YoY Change 826.13% -65.76%
Interest Expense $130.0K $220.0K
YoY Change -40.91% 57.14%
% of Operating Profit 3.5% 54.87%
Other Income/Expense, Net
YoY Change
Pretax Income $3.847M $624.2K
YoY Change 516.35% -52.21%
Income Tax $684.0K $123.0K
% Of Pretax Income 17.78% 19.71%
Net Earnings $3.163M $501.2K
YoY Change 531.14% -50.38%
Net Earnings / Revenue 11.68% 2.59%
Basic Earnings Per Share $0.23 $0.04
Diluted Earnings Per Share $0.23 $0.04
COMMON SHARES
Basic Shares Outstanding 13.69M 13.51M
Diluted Shares Outstanding 13.70M 13.62M

Balance Sheet

Concept 2020 Q4 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.30M $25.10M
YoY Change 12.75% 5.46%
Cash & Equivalents $19.15M $10.59M
Short-Term Investments $9.100M $14.50M
Other Short-Term Assets $449.6K $825.1K
YoY Change -45.51% 26.31%
Inventory $13.69M $10.63M
Prepaid Expenses
Receivables $9.798M $7.026M
Other Receivables $0.00 $0.00
Total Short-Term Assets $52.21M $43.59M
YoY Change 19.77% 3.06%
LONG-TERM ASSETS
Property, Plant & Equipment $5.003M $5.682M
YoY Change -11.96% 23.73%
Goodwill $4.709M $4.709M
YoY Change 0.0% 0.0%
Intangibles $4.747M $5.060M
YoY Change -6.17% -5.99%
Long-Term Investments $26.10M $21.70M
YoY Change 20.28% 18.58%
Other Assets $266.5K $202.5K
YoY Change 31.59% -5.32%
Total Long-Term Assets $43.98M $39.57M
YoY Change 11.13% 19.23%
TOTAL ASSETS
Total Short-Term Assets $52.21M $43.59M
Total Long-Term Assets $43.98M $39.57M
Total Assets $96.19M $83.16M
YoY Change 15.66% 10.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.866M $2.316M
YoY Change -19.42% 20.74%
Accrued Expenses $1.909M $327.2K
YoY Change 483.59% -62.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.769M $5.280M
YoY Change 47.13% 15.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.300M $1.900M
YoY Change 21.05% 533.33%
Total Long-Term Liabilities $2.307M $2.042M
YoY Change 13.01% 453.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.769M $5.280M
Total Long-Term Liabilities $2.307M $2.042M
Total Liabilities $10.08M $7.322M
YoY Change 37.62% 48.78%
SHAREHOLDERS EQUITY
Retained Earnings $28.28M $18.32M
YoY Change 54.34% 28.44%
Common Stock $137.3K $136.6K
YoY Change 0.52% -0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $86.11M $75.84M
YoY Change
Total Liabilities & Shareholders Equity $96.19M $83.16M
YoY Change 15.66% 10.17%

Cashflow Statement

Concept 2020 Q4 2019 Q4
OPERATING ACTIVITIES
Net Income $3.163M $501.2K
YoY Change 531.14% -50.38%
Depreciation, Depletion And Amortization $568.0K $607.0K
YoY Change -6.42% 14.65%
Cash From Operating Activities $2.716M -$99.83K
YoY Change -2820.6% -101.46%
INVESTING ACTIVITIES
Capital Expenditures $378.9K $788.5K
YoY Change -51.95% 185.06%
Acquisitions
YoY Change
Other Investing Activities $460.0K $1.230M
YoY Change -62.6% 925.0%
Cash From Investing Activities $79.00K $438.5K
YoY Change -81.99% -383.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $179.0K $169.7K
YoY Change 5.51% -216.25%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$94.00K 166.4K
YoY Change -156.48% 19.49%
NET CHANGE
Cash From Operating Activities $2.716M -99.83K
Cash From Investing Activities $79.00K 438.5K
Cash From Financing Activities -$94.00K 166.4K
Net Change In Cash $2.701M 505.1K
YoY Change 434.71% -92.58%
FREE CASH FLOW
Cash From Operating Activities $2.716M -$99.83K
Capital Expenditures $378.9K $788.5K
Free Cash Flow $2.337M -$888.3K
YoY Change -363.1% -113.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 clfd Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
38973505
CY2020Q3 clfd Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
37664633
CY2020Q4 clfd Increase Decrease In Accounts Payable Accrued Expenses And Deferred Rent
IncreaseDecreaseInAccountsPayableAccruedExpensesAndDeferredRent
-2859717
CY2019Q4 clfd Increase Decrease In Accounts Payable Accrued Expenses And Deferred Rent
IncreaseDecreaseInAccountsPayableAccruedExpensesAndDeferredRent
-1848409
CY2020Q4 clfd Issuance Of Common Stock Funded Through Shares Sold To Company
IssuanceOfCommonStockFundedThroughSharesSoldToCompany
996182
CY2019Q4 clfd Issuance Of Common Stock Funded Through Shares Sold To Company
IssuanceOfCommonStockFundedThroughSharesSoldToCompany
CY2020Q4 clfd Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
CY2020Q4 clfd Number Of Patents Granted
NumberOfPatentsGranted
26
CY2020Q4 clfd Revenues Percent
RevenuesPercent
1
CY2019Q4 clfd Revenues Percent
RevenuesPercent
1
CY2020Q4 clfd Stock Issued During Period Value Stock Options Exercised Net Of Shares Exchanged For Payment
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesExchangedForPayment
-262470
CY2019Q4 clfd Stock Issued During Period Value Stock Options Exercised Net Of Shares Exchanged For Payment
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesExchangedForPayment
2580
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1866249
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3689587
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9797641
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10496672
CY2020Q4 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
CY2019Q4 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
28051
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1909236
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1202753
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
3118895
CY2020Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
4856885
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
57696847
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
57502905
CY2020Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10947
CY2019Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5803
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
289057
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
240586
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
289057
CY2019Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
240586
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
289085
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
289085
CY2020Q4 us-gaap Assets
Assets
96187684
CY2020Q4 dei Entity Central Index Key
EntityCentralIndexKey
0000796505
CY2020Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2020Q4 dei Trading Symbol
TradingSymbol
clfd
CY2020Q4 dei Amendment Flag
AmendmentFlag
false
CY2020Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q4 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020Q4 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13727906
CY2020Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 dei Entity Registrant Name
EntityRegistrantName
Clearfield, Inc.
CY2020Q4 dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q4 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2020Q3 us-gaap Assets
Assets
95297430
CY2020Q4 us-gaap Assets Current
AssetsCurrent
52211429
CY2020Q3 us-gaap Assets Current
AssetsCurrent
52522809
CY2020Q4 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font: inherit;">1.</div> Basis of Presentation</div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><div style="display: inline; color: black">The accompanying (a) condensed balance sheet as of <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2020, </div>which has been derived from audited financial statements, and (b) unaudited interim condensed financial statements as of and for the <div style="display: inline; font-style: italic; font: inherit;">three</div> months ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020 </div>have been prepared by Clearfield, Inc. (the &#x201c;Company&#x201d;) in accordance with accounting principles generally accepted in the United States of America for interim financial information, pursuant to the rules and regulations of the Securities and Exchange Commission. Pursuant to these rules and regulations, certain financial information and footnote disclosures normally included in the financial statements have been condensed or omitted. However, in the opinion of management, the financial statements include all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of the financial position, results of operations and cash flows of the interim periods presented. </div>Operating results for the interim periods presented are <div style="display: inline; font-style: italic; font: inherit;">not</div> necessarily indicative of results to be expected for the full year or for any other interim period, due to variability in customer purchasing patterns and seasonal, operating and other factors. <div style="display: inline; color: black">These condensed financial statements should be read in conjunction with the financial statements and notes thereto included in the Company's Annual Report on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2020.</div></div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In preparation of the Company's financial statements, management is required to make estimates and assumptions that affect reported amounts of assets and liabilities and related revenues and expenses during the reporting periods. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><div style="display: inline; font-weight: bold;">New Accounting Pronouncements</div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In <div style="display: inline; font-style: italic; font: inherit;"> January 2017, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font: inherit;">2017</div>-<div style="display: inline; font-style: italic; font: inherit;">04,</div> Intangibles-Goodwill, which offers amended guidance to simplify the accounting for goodwill impairment by removing Step <div style="display: inline; font-style: italic; font: inherit;">2</div> of the goodwill impairment test. A goodwill impairment will now be measured as the amount by which a reporting unit's carrying value exceeds its fair value, limited to the amount of goodwill allocated to that reporting unit. This guidance is to be applied on a prospective basis effective for the Company's interim and annual periods beginning after <div style="display: inline; font-style: italic; font: inherit;"> December 15, 2019. </div>The new guidance is effective for the Company beginning in the <div style="display: inline; font-style: italic; font: inherit;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font: inherit;">2021.</div> The adoption of ASU <div style="display: inline; font-style: italic; font: inherit;">2017</div>-<div style="display: inline; font-style: italic; font: inherit;">04</div> did <div style="display: inline; font-style: italic; font: inherit;">not</div> have a material impact on the Company's financial statements.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In <div style="display: inline; font-style: italic; font: inherit;"> June 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font: inherit;">2016</div>-<div style="display: inline; font-style: italic; font: inherit;">13,</div> Measurement of Credit Losses on Financial Instruments. In <div style="display: inline; font-style: italic; font: inherit;"> November 2018, </div>the FASB issued update ASU <div style="display: inline; font-style: italic; font: inherit;">2018</div>-<div style="display: inline; font-style: italic; font: inherit;">19</div> that clarifies the scope of the standard in the amendments in ASU <div style="display: inline; font-style: italic; font: inherit;">2016</div>-<div style="display: inline; font-style: italic; font: inherit;">13.</div> This guidance introduces a new model for recognizing credit losses on financial instruments based on an estimate of current expected credit losses. Financial instruments impacted include accounts receivable, trade receivables, other financial assets measured at amortized cost and other off-balance sheet credit exposures. The new guidance is effective for the Company beginning in the <div style="display: inline; font-style: italic; font: inherit;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font: inherit;">2023,</div> with early adoption permitted. The Company is evaluating the impact of the adoption of ASU <div style="display: inline; font-style: italic; font: inherit;">2016</div>-<div style="display: inline; font-style: italic; font: inherit;">13</div> on our financial statements.</div></div>
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19151076
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16449636
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16449636
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10081721
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19151076
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10586850
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2701440
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
505129
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13727906
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13649962
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13727906
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13649962
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
137279
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
136500
CY2020Q4 us-gaap Cost Of Revenue
CostOfRevenue
15722902
CY2019Q4 us-gaap Cost Of Revenue
CostOfRevenue
11650456
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
178118
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
178118
CY2020Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
567718
CY2019Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
606972
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.178
CY2019Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.197
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3429805
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y255D
CY2020Q4 us-gaap Goodwill
Goodwill
4708511
CY2020Q3 us-gaap Goodwill
Goodwill
4708511
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q4 us-gaap Gross Profit
GrossProfit
11369245
CY2019Q4 us-gaap Gross Profit
GrossProfit
7727535
CY2020Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
35267527
CY2020Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
35725527
CY2020Q4 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
26142000
CY2020Q3 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
25143000
CY2020Q4 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
9125527
CY2020Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
10582527
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3847439
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
624158
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
684000
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
123000
CY2020Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
17000
CY2019Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
29907
CY2020Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-699031
CY2019Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2092912
CY2020Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-720949
CY2019Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1617461
CY2020Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-136182
CY2019Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
47538
CY2020Q4 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
4282
CY2019Q4 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
110132
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4747450
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4829047
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2233090
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2048514
CY2020Q4 us-gaap Inventory Gross
InventoryGross
14675724
CY2020Q3 us-gaap Inventory Gross
InventoryGross
15368669
CY2020Q4 us-gaap Inventory Net
InventoryNet
13687589
CY2020Q3 us-gaap Inventory Net
InventoryNet
14408538
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
11475903
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
12287134
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
988135
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
960131
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
966731
CY2020Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1033021
CY2020Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
133731
CY2019Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
223243
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3390586
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
986844
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
217552
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
516725
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
943682
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
725783
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
208720
CY2020Q4 us-gaap Liabilities
Liabilities
10076246
CY2020Q3 us-gaap Liabilities
Liabilities
12544152
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
96187684
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
95297430
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7768856
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10414809
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2307390
CY2020Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2129343
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
26142000
CY2020Q3 us-gaap Long Term Investments
LongTermInvestments
25143000
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-94336
CY2019Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
166429
CY2020Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
79117
CY2019Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
438531
CY2020Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2716659
CY2019Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-99831
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
3163439
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
501158
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
3713708
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
400915
CY2020Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
308334
CY2019Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
241994
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3181866
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
874476
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
665584
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2307390
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2129343
CY2020Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
239735
CY2019Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
167840
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2930911
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2539100
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.034
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0351
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y204D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y343D
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
449596
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
585436
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
266515
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
266857
CY2020Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10947
CY2019Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5803
CY2020Q4 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3968000
CY2019Q4 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3211000
CY2020Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
378883
CY2019Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
788469
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
179081
CY2019Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
169652
CY2020Q4 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
4426000
CY2019Q4 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
4438000
CY2020Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
85
CY2019Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2580
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5002750
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5109988
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
28277312
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
25113873
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27092147
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19377991
CY2020Q3 us-gaap Short Term Investments
ShortTermInvestments
10582527
CY2020Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
79400
CY2020Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
179081
CY2019Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
169652
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7655537
CY2019Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7326620
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
289057
CY2019Q4 us-gaap Share Based Compensation
ShareBasedCompensation
240586
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y284D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.469
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0024
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
105089
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
116600
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.14
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1173691
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
337100
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
362789
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.48
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.73
CY2020Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.55
CY2020Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
23.74
CY2019Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.43
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y284D
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y237D
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
9125527
CY2020Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
86111438
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13692533
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13512094
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
82753278
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
74933387
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
75841560
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13696815
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13622226

Files In Submission

Name View Source Status
0001171843-21-000707-index-headers.html Edgar Link pending
0001171843-21-000707-index.html Edgar Link pending
0001171843-21-000707.txt Edgar Link pending
0001171843-21-000707-xbrl.zip Edgar Link pending
clfd-20201231.xml Edgar Link completed
clfd-20201231.xsd Edgar Link pending
clfd-20201231_cal.xml Edgar Link unprocessable
clfd-20201231_def.xml Edgar Link unprocessable
clfd-20201231_lab.xml Edgar Link unprocessable
clfd-20201231_pre.xml Edgar Link unprocessable
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
f10q_020321p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending